Health Sciences Acquisitions Corp (HSAQ)
$13.31
As on 26-Jan-2023 15:59EDT
Market cap
$149 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-2 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-48.3
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
11,212,100
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Health Sciences Acquisitions Corp (HSAQ)
| 33.4 | 33.5 | 33.8 | 35.1 | -- | -- | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
|---|---|---|
|
Health Sciences Acquisitions Corp (HSAQ)
| -1.0 | -21.3 |
|
S&P Small-Cap 600
| -17.4 | 25.3 |
|
BSE Sensex
| 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Health Sciences Acquisitions Corp (HSAQ)
|
13.3 | 149.2 | 0.0 | -2.7 | -- | 50.2 | -- | 1.8 |
| 10.2 | 439.4 | 0.0 | 6,651,083.5 | -- | -- | 84.9 | 1.3 |
Shareholding Pattern
View DetailsAbout Health Sciences Acquisitions Corp (HSAQ)
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more... businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York. Read more
-
Pres, CEO & Chairman
Dr. Roderick Tze Ian Wong M.D.
-
Pres, CEO & Chairman
Dr. Roderick Tze Ian Wong M.D.
-
Headquarters
New York, NY
-
Website
--
FAQs for Health Sciences Acquisitions Corp (HSAQ)
What is the current share price of Health Sciences Acquisitions Corp (HSAQ) Today?
The share price of Health Sciences Acquisitions Corp (HSAQ) is $13.31 (NASDAQ) as of 26-Jan-2023 15:59 EDT. Health Sciences Acquisitions Corp (HSAQ) has given a return of 35.13% in the last 1 years.
What is the current PB & PE ratio of Health Sciences Acquisitions Corp (HSAQ)?
Since, TTM earnings of Health Sciences Acquisitions Corp (HSAQ) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
What is the 52 Week High and Low of Health Sciences Acquisitions Corp (HSAQ)?
The 52-week high and low of Health Sciences Acquisitions Corp (HSAQ) are Rs -- and Rs -- as of 02-Sep-2026.
What is the market cap of Health Sciences Acquisitions Corp (HSAQ)?
Health Sciences Acquisitions Corp (HSAQ) has a market capitalisation of $ 149 Mln as on 27-Jan-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Health Sciences Acquisitions Corp (HSAQ)?
Before investing in Health Sciences Acquisitions Corp (HSAQ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.